Clinical Trial Update: Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma

View source ↗

Summary

A completed clinical trial comparing intraoperative versus postoperative intravesical epirubicin to prevent bladder recurrence in high-risk upper tract urotheli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Upper Tract Urothelial Carcinoma

Drugs mentioned

• Epirubicin (epirubicin)

Snippet

Sponsor: Ankara Etlik City Hospital | Conditions: Bladder Cancer Recurrence, Intravesical Instillation | Status: COMPLETED